
BHVN Valuation
Biohaven Ltd
- Overview
- Forecast
- Valuation
- Earnings
BHVN Relative Valuation
BHVN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BHVN is overvalued; if below, it's undervalued.
Historical Valuation
Biohaven Ltd (BHVN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 241.21 is considered Undervalued compared with the five-year average of -4.57. The fair price of Biohaven Ltd (BHVN) is between 28.78 to 34.35 according to relative valuation methord. Compared to the current price of 13.49 USD , Biohaven Ltd is Undervalued By 53.12%.
Relative Value
Fair Zone
28.78-34.35
Current Price:13.49
53.12%
Undervalued
-1.85
PE
1Y
3Y
5Y
Trailing
Forward
-1.59
EV/EBITDA
Biohaven Ltd. (BHVN) has a current EV/EBITDA of -1.59. The 5-year average EV/EBITDA is -3.67. The thresholds are as follows: Strongly Undervalued below -9.48, Undervalued between -9.48 and -6.58, Fairly Valued between -0.77 and -6.58, Overvalued between -0.77 and 2.14, and Strongly Overvalued above 2.14. The current Forward EV/EBITDA of -1.59 falls within the Historic Trend Line -Fairly Valued range.
-1.34
EV/EBIT
Biohaven Ltd. (BHVN) has a current EV/EBIT of -1.34. The 5-year average EV/EBIT is -3.97. The thresholds are as follows: Strongly Undervalued below -7.48, Undervalued between -7.48 and -5.72, Fairly Valued between -2.22 and -5.72, Overvalued between -2.22 and -0.47, and Strongly Overvalued above -0.47. The current Forward EV/EBIT of -1.34 falls within the Overvalued range.
241.21
PS
Biohaven Ltd. (BHVN) has a current PS of 241.21. The 5-year average PS is 74140.57. The thresholds are as follows: Strongly Undervalued below -406128.27, Undervalued between -406128.27 and -165993.85, Fairly Valued between 314274.99 and -165993.85, Overvalued between 314274.99 and 554409.41, and Strongly Overvalued above 554409.41. The current Forward PS of 241.21 falls within the Historic Trend Line -Fairly Valued range.
-2.38
P/OCF
Biohaven Ltd. (BHVN) has a current P/OCF of -2.38. The 5-year average P/OCF is -6.11. The thresholds are as follows: Strongly Undervalued below -10.31, Undervalued between -10.31 and -8.21, Fairly Valued between -4.01 and -8.21, Overvalued between -4.01 and -1.91, and Strongly Overvalued above -1.91. The current Forward P/OCF of -2.38 falls within the Overvalued range.
-1.96
P/FCF
Biohaven Ltd. (BHVN) has a current P/FCF of -1.96. The 5-year average P/FCF is -7.68. The thresholds are as follows: Strongly Undervalued below -17.73, Undervalued between -17.73 and -12.70, Fairly Valued between -2.66 and -12.70, Overvalued between -2.66 and 2.37, and Strongly Overvalued above 2.37. The current Forward P/FCF of -1.96 falls within the Overvalued range.
Biohaven Ltd (BHVN) has a current Price-to-Book (P/B) ratio of 5.31. Compared to its 3-year average P/B ratio of 7.50 , the current P/B ratio is approximately -29.17% higher. Relative to its 5-year average P/B ratio of 7.50, the current P/B ratio is about -29.17% higher. Biohaven Ltd (BHVN) has a Forward Free Cash Flow (FCF) yield of approximately -47.08%. Compared to its 3-year average FCF yield of -19.80%, the current FCF yield is approximately 137.76% lower. Relative to its 5-year average FCF yield of -19.80% , the current FCF yield is about 137.76% lower.
5.31
P/B
Median3y
7.50
Median5y
7.50
-47.08
FCF Yield
Median3y
-19.80
Median5y
-19.80
Competitors Valuation Multiple
The average P/S ratio for BHVN's competitors is 1667.53, providing a benchmark for relative valuation. Biohaven Ltd Corp (BHVN) exhibits a P/S ratio of 241.21, which is -85.53% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BHVN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BHVN in the past 1 year is driven by Unknown.
People Also Watch

ADMA
ADMA Biologics Inc
18.000
USD
-0.06%

MDU
MDU Resources Group Inc
16.880
USD
-0.82%

RUSHA
Rush Enterprises Inc
54.750
USD
-0.13%

CPA
Copa Holdings SA
109.030
USD
-0.99%

PI
Impinj Inc
126.130
USD
+1.51%

EBC
Eastern Bankshares Inc
16.120
USD
+1.00%

MHO
M/I Homes Inc
123.340
USD
+0.94%

FULT
Fulton Financial Corp
18.620
USD
+0.11%

ALE
ALLETE Inc
65.900
USD
+0.05%

PJT
PJT Partners Inc
182.520
USD
-0.86%
FAQ

Is Biohaven Ltd (BHVN) currently overvalued or undervalued?
Biohaven Ltd (BHVN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 241.21 is considered Undervalued compared with the five-year average of -4.57. The fair price of Biohaven Ltd (BHVN) is between 28.78 to 34.35 according to relative valuation methord. Compared to the current price of 13.49 USD , Biohaven Ltd is Undervalued By 53.12% .

What is Biohaven Ltd (BHVN) fair value?

How does BHVN's valuation metrics compare to the industry average?

What is the current P/B ratio for Biohaven Ltd (BHVN) as of Jul 29 2025?

What is the current FCF Yield for Biohaven Ltd (BHVN) as of Jul 29 2025?

What is the current Forward P/E ratio for Biohaven Ltd (BHVN) as of Jul 29 2025?
